Background: Multiple reforms have been instigated across Europe to enhance prescribing
efficiency. Supply-side reforms in the Republic of Serbia include measures to lower the price …

European countries strive to enhance prescribing efficiency. This includes renin–
angiotensin drugs following the availability of generic angiotensin-converting enzyme …

Aim: To assess the utilization of renin–angiotensin drugs, including combinations, in Austria
in practice given the limited availability of diuretics, as well as the impact of recent reforms …

Introduction: Pharmaceutical expenditure is rising by 16% per annum in China and is now
46% of total expenditure. Initiatives to moderate growth include drug pricing regulations and …

Background: Multiple reforms have been introduced in the Republic of Srpska to enhance
prescribing efficiency. Objectives: First, assess their influence on utilization and expenditure …

Background: Generic losartan provides an opportunity to enhance angiotensin receptor
blocker (ARB) prescribing efficiency, with all ARBs essentially being similar. Initially, there …

Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple
initiatives across Europe to lower generic prices and enhance their utilization. However …

Objective Compare the utilisation of losartan before and after the availability of generics in
Belgium and its inclusion in the reference price system, which changed its reimbursement …

Introduction: European countries need to learn from each other to address unsustainable
increases in pharmaceutical expenditures. Objective: To assess the influence of the many …

Background There are on-going initiatives in Scotland to improve the quality and efficiency
of prescribing in primary care. Activities to enhance prescribing of angiotensin-converting …